{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/premenstrual-syndrome/diagnosis/diagnosis/","result":{"pageContext":{"chapter":{"id":"62cca645-8d11-506e-b89c-d03bb2e3c67e","slug":"diagnosis","fullItemName":"Diagnosis","depth":2,"htmlHeader":"<!-- begin field 9528f25c-03ea-4662-bc7b-09ec42f4ca2a --><h2>How should I diagnose premenstrual syndrome?</h2><!-- end field 9528f25c-03ea-4662-bc7b-09ec42f4ca2a -->","summary":"","htmlStringContent":"<!-- begin item db15482b-b284-451c-841c-fee41325ce62 --><!-- begin field d6a0a5d9-2d76-4324-909a-3f836f976f4f --><ul><li><strong>Take a history. </strong>Ask about:<ul><li>The types of symptoms experienced, including:<ul><li>Psychological symptoms, such as mood swings, irritability, depressed mood, anxiety, feeling out of control, poor concentration, change in libido, and food cravings.</li><li>Physical symptoms, such as breast tenderness, bloating, headaches, backache, weight gain, acne, and gastrointestinal disturbance.</li><li>Behavioural symptoms, such as reduced visio-spatial and cognitive ability, aggression, and increase in accidents.</li></ul></li><li>The timing of symptoms in relation to the menstrual cycle. If appropriate, also ask about the presence of symptoms before, during, and after pregnancy.</li><li>The severity of the symptoms and the degree of impact on daily activity. In particular, ask about the effect of symptoms on the woman's work, school, family life, and interpersonal relationships.</li><li>The woman's medication history, including:<ul><li>Any previous treatment tried and whether symptoms improved with the treatment.</li><li>Other current medications, including contraceptives.</li></ul></li><li>The woman's medical history. In particular, ask about:<ul><li>Any underlying chronic illness (such as diabetes, depression, epilepsy, asthma, and migraine) and whether symptoms of the illness significantly worsen premenstrually.</li><li>A history of mood disorders.</li><li>Any surgical procedures (such as a hysterectomy or endometrial ablation).</li></ul></li><li>Other possible <a class=\"topic-reference internal-reference\" href=\"/topics/premenstrual-syndrome/background-information/risk-factors/\">risk factors</a> for premenstrual syndrome (PMS), including smoking and alcohol use.</li></ul></li><li><strong>Perform a physical examination as indicated by the woman's age and routine gynaecological and medical recommendations. </strong><ul><li>If the woman has pelvic pain or abdominal swelling, perform a full physical examination, including an abdominal and pelvic examination, to rule out any other underlying cause of their symptoms.</li></ul></li><li><strong>Ask the woman to record a daily symptom diary </strong><strong>for two or three cycles, and review the woman with the diary</strong><strong>. </strong><ul><li>The <a data-hyperlink-id=\"3c883c62-73d5-476b-8dfe-aa5100cfe6fc\" href=\"https://www.aafp.org/afp/2011/1015/afp20111015p918-fig1.pdf\">Daily Record of Severity of Problems</a> (DRSP) is a validated questionnaire that is widely used for tracking symptoms related to PMS. Other questionnaires are available.</li></ul></li><li><strong>Diagnose PMS if </strong>the symptom diary shows prominence of symptoms during the luteal phase of the menstrual cycle, which resolve with the onset of menses or soon after, followed by a symptom-free week.<ul><li>Symptoms should be severe enough to affect daily functioning or interfere with the woman's work, school, performance, or interpersonal relationships. </li><li>For the diagnosis of <a class=\"topic-reference internal-reference\" href=\"/topics/premenstrual-syndrome/background-information/definition/\">core premenstrual disorders</a> (PMDs), the most commonly encountered and widely recognized type of PMS, no other underlying disorder should be present.</li></ul></li><li><strong>If cyclical symptoms are not found, </strong>exclude <a class=\"topic-reference internal-reference\" href=\"/topics/premenstrual-syndrome/diagnosis/differential-diagnosis/\">other conditions</a> that could explain the symptoms, such as depression, hypothyroidism, anaemia, irritable bowel syndrome, and endometriosis.</li><li><strong>If the completed symptom diary alone is inconclusive</strong><strong>,</strong> refer the woman to secondary care. <ul><li>Symptom diaries can sometimes be confusing and/or inconclusive, especially in women with <a class=\"topic-reference internal-reference\" href=\"/topics/premenstrual-syndrome/background-information/definition/\">variant PMDs</a>.</li><li>Gonadotrophin-releasing hormone (GnRH) agonists are widely used by gynaecologists to establish a definitive diagnosis of PMS by inhibiting cyclical ovarian function. They are used for 3 months (a month for the agonist to generate a complete hormonal suppressive effect plus 2 months’ worth of symptom diaries). Resolution of symptoms after ovarian suppression is considered diagnostic for PMS.</li></ul></li></ul><!-- end field d6a0a5d9-2d76-4324-909a-3f836f976f4f --><!-- end item db15482b-b284-451c-841c-fee41325ce62 -->","topic":{"id":"668a4b93-2e2a-5933-b12a-a5f9a6837daa","topicId":"f6d48374-0ddd-481d-bd35-f505fee5c47c","topicName":"Premenstrual syndrome","slug":"premenstrual-syndrome","lastRevised":"Last revised in May 2019","chapters":[{"id":"be47d0f4-3261-5657-aed1-da0bf6c8646b","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"8a1b7572-de88-506c-b0a1-1abc9c2b3400","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"6b9c9d21-76ac-5aeb-8eb1-6691f5ceeebf","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"35972086-c065-56c4-b666-e4587fdcf93f","slug":"changes","fullItemName":"Changes"},{"id":"1514e449-0c67-5287-89db-b28b88262141","slug":"update","fullItemName":"Update"}]},{"id":"77ec7d7d-940c-500d-a1ba-cfbab291e38e","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"7e8b32dc-1aa1-5788-97c8-df04afc2b0d7","slug":"goals","fullItemName":"Goals"},{"id":"4aaf0515-7ef4-50cd-ac12-5b17be6cd5e2","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"0acf2aa6-23e0-570b-b29e-dfdacdf474e8","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"3c135ec7-461a-543c-b44d-ee843697d5cd","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d791fb42-e91f-59e0-8c0c-b0f37f0af9d8","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"8f27bc31-6f00-5859-81f7-ef752b747fd6","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"0b4b11ef-5cde-5735-afba-4776dc10d844","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"6f01cc3d-bae7-5d66-94b4-d8e7557c2fef","slug":"definition","fullItemName":"Definition"},{"id":"d13f731a-5216-537d-87a7-ffcd99337439","slug":"causes","fullItemName":"Causes"},{"id":"ab110573-4a7f-55d9-9b69-dd1a01720cc0","slug":"prevalence","fullItemName":"Prevalence"},{"id":"4dcf143b-4961-5298-b7db-b287cf1ca668","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"bc7d0c7b-0738-5636-8178-568fde4f6a9d","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"6d13f640-7df8-5329-b316-427a1fb36947","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"62cca645-8d11-506e-b89c-d03bb2e3c67e","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"327a606c-ee03-58eb-93aa-e273d6cdaf19","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"a4d3cc19-5d97-5502-82ee-faaa3b8d70eb","fullItemName":"Management","slug":"management","subChapters":[{"id":"59536afb-24d2-5bcd-9547-0956da541574","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"420b10d2-e907-5756-8ca3-6664d9a52e79","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"9d7a5734-a47f-5d7b-b5c6-402c6770e572","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"3ad740b3-87b5-5561-8b71-95159af00e56","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"701680b6-e2f2-5417-8ce9-fbe9fac6dafa","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"17f9f3a8-f341-5f94-b234-1858b76e2615","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"048dd1e9-197a-52dc-b5e6-45257f78f081","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"f78990a8-e11f-56f2-a80c-8d73ce908b65","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"81d3d1c5-c389-54b3-8764-34fbee70bb6b","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"6d13f640-7df8-5329-b316-427a1fb36947","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"0a96d5d6-cd27-5dc8-9a7f-c1eb21ec1b80","slug":"basis-for-recommendation-1e2","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 8b3100ff-ab00-4059-8f82-88e03013b155 --><h3>Basis for recommendation</h3><!-- end field 8b3100ff-ab00-4059-8f82-88e03013b155 -->","summary":null,"htmlStringContent":"<!-- begin item 1e2ec0a2-8c01-4f82-96c6-10cb45c7633c --><!-- begin field 4204c0ef-1eb2-4b7d-8bcc-9e4f124e884a --><p>These recommendations are based on the Royal College of Obstetricians and Gynaecologists (RCOG) guideline <em>Management of Premenstrual Syndrome</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">BJOG, 2016</a>], the <em>Fourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">Ismaili, 2016</a>], and expert opinion in review articles on premenstrual syndrome (PMS) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">Hofmeister, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">Reid, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">BMJ, 2018</a>].</p><h4>Taking a history</h4><ul><li>Experts agree that taking a full history, including menstrual history, is paramount to distinguish PMS from physiological premenstrual symptoms [<a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">Ismaili, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">Reid, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">BMJ, 2018</a>]. Laboratory testing and imaging are not routinely recommended but may be considered to rule out differential diagnoses of PMS [<a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">Hofmeister, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">BMJ, 2018</a>].<ul><li>Women who experience minor, transient premenstrual symptoms (such as such as abdominal bloating [most common], breast tenderness, headache, acne, constipation, or minor mood changes) that do not cause impairment of activities of daily living or affect quality of life are said to be experiencing premenstrual symptoms rather than PMS [<a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">Reid, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">BMJ, 2018</a>].</li></ul></li><li>The recommended questions to ask are based on expert opinion in the ISPMD guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">Ismaili, 2016</a>] and in a review article on PMS [<a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">BMJ, 2018</a>].</li></ul><h4>Physical examination</h4><ul><li>This recommendation is based on expert opinion in the ISPMD guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">Ismaili, 2016</a>] and in a review article on PMS [<a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">BMJ, 2018</a>].</li></ul><h4>Symptom diary</h4><ul><li>A daily symptom diary recorded over two cycles is recommended by the RCOG because, in their expert opinion, the retrospective recall of symptoms is unreliable [<a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">BJOG, 2016</a>]. Expert opinion in the ISPMD guideline is that a symptom diary is needed to obtain accurate symptoms and to demonstrate worsening symptoms during the premenstrual phase [<a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">Ismaili, 2016</a>]. Expert opinion in a review article is that a symptom diary will differentiate PMS from premenstrual exacerbations of other conditions and identify chronic disorders unrelated to the menstrual cycle [<a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">BMJ, 2018</a>].</li><li>The information on the Daily Record of Severity of Problems (DRSP) questionnaire is taken from the RCOG guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">BJOG, 2016</a>] and a review article on PMS [<a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">BMJ, 2018</a>].</li></ul><h4>Diagnosis of PMS</h4><ul><li>The recommendation on the diagnosis of PMS is based on the RCOG guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">BJOG, 2016</a>] and the ISPMD guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">Ismaili, 2016</a>].</li><li>The RCOG recommends that if diagnosis of PMS is unclear from 2 months’ prospective DRSP charting, gonadotrophin-releasing hormone (GnRH) agonists can be used to establish and/or support a diagnosis of PMS [<a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">BJOG, 2016</a>]. CKS recommends that this is done in secondary care.<ul><li>Although not licensed for this indication, this approach is assumed to be efficacious based on evidence supporting the use of GnRH agonists for the treatment of PMS [<a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">BJOG, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/premenstrual-syndrome/references/\">BMJ, 2018</a>].</li></ul></li></ul><!-- end field 4204c0ef-1eb2-4b7d-8bcc-9e4f124e884a --><!-- end item 1e2ec0a2-8c01-4f82-96c6-10cb45c7633c -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}